CPIG
ANIK icon

Chicago Partners Investment Group’s Anika Therapeutics ANIK Stock Holding History

Chicago Partners Investment Group’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-439
Closed -$15K – 343
2018
Q3 		$15K Hold
439
– – ﹤0.01% 732
2018
Q2 		$14K Hold
439
– – ﹤0.01% 729
2018
Q1 		$22K Buy
439
+263
+149% +$14.9K ﹤0.01% 606
2017
Q4 		$9K Sell
176
-263
-60% -$14.6K ﹤0.01% 759
2017
Q3 		$25K Buy
+439
New +$22.9K ﹤0.01% 570

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.57B AUM 19.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Chicago Partners Investment Group's ANIK Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of Anika Therapeutics (ANIK) in Q4 2018, closing a stake of 439 shares — an estimated $15K sold.

Chicago Partners Investment Group first reported a position in ANIK in Q3 2017 and held it in 5 quarters. The position peaked at $25K in Q3 2017. 162 funds tracked by Wall St. Rank hold ANIK as of Q4 2018.

  • Chicago Partners Investment Group reported no remaining Anika Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 439 Anika Therapeutics shares in Q4 2018, an estimated $15K.
  • Chicago Partners Investment Group first reported a position in Anika Therapeutics in Q3 2017 and held it in 5 quarters.
  • Chicago Partners Investment Group's Anika Therapeutics position peaked at $25K in Q3 2017.
  • 162 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.